Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition

被引:39
作者
Aziz, Diana Edwar [1 ]
Abdelbary, Aly Ahmed [1 ,2 ]
Elassasy, Abdelhalim Ibrahim [1 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 11562, Egypt
[2] October 6 Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Giza 6, Egypt
关键词
Diacerein; central composite; niosomes; optimization; ex vivo permeation; skin deposition studies; OCULAR DELIVERY-SYSTEM; BOX-BEHNKEN DESIGN; VITRO CHARACTERIZATION; SKIN PERMEATION; PARTICLE-SIZE; OPTIMIZATION; LIPOSOMES; FORMULATION; VESICLES; GEL;
D O I
10.2174/1567201815666180619105419
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Niosomes are surfactant-based vesicular nanosystems that proved their efficiency in transdermal delivery by overcoming skin inherent anatomic barrier; startum corneum. Central composite design is an efficient tool for developing and optimizing niosomal formulations using fewer experiments. Objective: The objective of this study was to prepare niosomes as a transdermal delivery system of diacerein using film hydration technique, employing central composite design, for avoiding its oral gastrointestinal problems. Methods: Three-level three-factor central composite design was employed for attaining optimal niosomes formulation with the desired characteristics. Three formulation variables were assessed: amount of salt in hydration medium (X-1), lipid amount (X-2) and number of surfactant parts (X-3). DCN-loaded niosomes were evaluated for entrapment efficiency percent (Y-1), particle size (Y-2), polydispersity index (Y-3) and zeta potential (Y-4). The suggested optimal niosomes were subjected to further characterization and utilized as a nucleus for developing elastic vesicles for comparative ex vivo and in vivo studies. Results: The values of the independent variables (X-1 , X-2 and X-3) in the optimal niosomes formulation were 0 g, 150 mg and 5 parts, respectively. It showed entrapment efficiency percentage of 95.63%, particle size of 436.65 nm, polydispersity index of 0.47 and zeta potential of -38.80 mV. Results of ex vivo permeation and skin deposition studies showed enhanced skin permeation and retention capacity of the prepared vesicles than drug suspension. Conclusion: Results revealed that a transdermal niosomal system was successfully prepared and evaluated using central composite design which will result in delivering diacerein efficiently, avoiding its oral problems.
引用
收藏
页码:1330 / 1342
页数:13
相关论文
共 69 条
[1]  
Abdallah MH., 2013, INT J PHARM PHARM SC, V5, P560
[2]   Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study [J].
Abdelbary, Aly A. ;
AbouGhaly, Mohamed H. H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 485 (1-2) :235-243
[3]   Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: Physicochemical characterization [J].
Abdelkader, H. ;
Ismail, S. ;
Kamal, A. ;
Alany, R. G. .
PHARMAZIE, 2010, 65 (11) :811-817
[4]   Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone [J].
Abdelrahman, Fatma Elzahraa ;
Elsayed, Ibrahim ;
Gad, Mary Kamal ;
Elshafeey, Ahmed Hassen ;
Mohamed, Magdi Ibrahim .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) :1-11
[5]  
Ahmed A., 2013, Int. J. Pharm. Pharm. Sci, V5, P229
[6]   Evaluation of Pharmacokinetic, Biodistribution, Pharmacodynamic, and Toxicity Profile of Free Juglone and Its Sterically Stabilized Liposomes [J].
Aithal, B. Kiran ;
Kumar, M. R. Sunil ;
Rao, B. Nageshwar ;
Upadhya, Raghavendra ;
Prabhu, Vijendra ;
Shavi, Gopal ;
Arumugam, Karthik ;
Sajankila, Shyama Prasad ;
Udupa, N. ;
Satyamoorthy, K. ;
Rao, B. S. Satish .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) :3517-3528
[7]   Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam [J].
Al-mahallawi, Abdulaziz M. ;
Abdelbary, Aly A. ;
Aburahma, Mona H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 485 (1-2) :329-340
[8]   Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: In-vitro optimization, ex-vivo permeation studies, and in-vivo assessment [J].
Al-mahallawi, Abdulaziz Mohsen ;
Khowessah, Omneya Mohammed ;
Shoukri, Raguia Ali .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 472 (1-2) :304-314
[9]  
ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
[10]   Beware of R2: Simple, Unambiguous Assessment of the Prediction Accuracy of QSAR and QSPR Models [J].
Alexander, D. L. J. ;
Tropsha, A. ;
Winkler, David A. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2015, 55 (07) :1316-1322